Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/13/2025

Atrial Fibrillation Management

Anticoagulation and Cardioversion

  • The American College of Chest Physicians recommends continuing therapeutic anticoagulation before, during, and after the procedure for atrial fibrillation greater than 48 hours or unknown duration, with a target INR of 2.0-3.0 for patients on warfarin 1, 2, 3
  • For patients using heparin, the American College of Chest Physicians suggests administering intravenous unfractionated heparin at the time of transesophageal echocardiography (TEE) and performing cardioversion within 24 hours if no thrombus is seen, with therapeutic levels of heparin (aPTT 1.5-2 times control value) maintained during TEE-guided cardioversion 1, 2, 3
  • The American College of Cardiology recommends that patients with atrial fibrillation undergoing elective cardioversion with TEE guidance should be on therapeutic anticoagulation with factor Xa inhibitors for at least 3 weeks before cardioversion, and anticoagulation should be continued for at least 4 weeks after cardioversion regardless of rhythm outcome 1, 4
  • Cardioversion should be performed within 24 hours of a thrombus-negative TEE, as recommended by the American College of Chest Physicians and the American Heart Association 1, 5

High-Risk Patients

  • Patients with mechanical heart valves are at high risk for thromboembolism when anticoagulation is interrupted, according to the American Heart Association, and bridging therapy with low-molecular-weight heparin (LMWH) or unfractionated heparin should be considered for these patients 5, 6
  • High thrombotic risk patients, including those with recent venous thromboembolism (<3 months), active cancer, or mechanical heart valves, should be identified and managed accordingly, with minimized time off anticoagulation for cancer patients 7, 8

Left Atrial Appendage Thrombus

  • If a left atrial appendage thrombus is identified on TEE, the American College of Cardiology recommends postponing cardioversion and administering anticoagulation for at least 3-4 weeks before attempting cardioversion again 4
  • The American College of Chest Physicians recommends careful management of anticoagulation before Transesophageal Echocardiography (TEE) procedures to minimize bleeding complications, with a target INR < 1.5 for safe TEE procedure, and holding anticoagulation for at least 24 hours before the scheduled procedure for low-to-moderate bleeding risk TEE, and 48-72 hours for high bleeding risk TEE 1, 9

Periprocedural Anticoagulation Management

  • The American College of Cardiology suggests that aspirin can be continued for routine TEE, while clopidogrel should be held for 5 days before TEE if high bleeding risk is anticipated, and prasugrel should be held for 7 days before TEE, and ticagrelor should be held for 3 days before TEE 10, 11
  • No bridging therapy with heparin is required for a short interruption of factor Xa inhibitors, with the last dose given 24 hours before the scheduled TEE, and anti-factor Xa levels do not need to be routinely measured before TEE procedures, and the factor Xa inhibitor should be restarted the day after the procedure (approximately 24 hours post-procedure) 9, 7

REFERENCES

8

Venous Thromboembolism Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025